|
LOC729082 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.192700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.3094999999993E-05 |
| Normal-vs-Stage2 |
1.520180E-01 |
| Normal-vs-Stage3 |
2.921400E-01 |
| Normal-vs-Stage4 |
5.598000E-01 |
| Stage1-vs-Stage2 |
4.295200E-01 |
| Stage1-vs-Stage3 |
1.367000E-01 |
| Stage1-vs-Stage4 |
2.863600E-01 |
| Stage2-vs-Stage3 |
7.036000E-01 |
| Stage2-vs-Stage4 |
7.265800E-01 |
| Stage3-vs-Stage4 |
9.532600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.195300E-04 |
| Normal-vs-AfricanAmerican |
1.054140E-02 |
| Normal-vs-Asian |
3.438100E-03 |
| Caucasian-vs-AfricanAmerican |
6.590400E-01 |
| Caucasian-vs-Asian |
4.380600E-01 |
| AfricanAmerican-vs-Asian |
3.409600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00969999997191E-06 |
| Normal-vs-Female |
7.038600E-01 |
| Male-vs-Female |
3.761900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.036100E-02 |
| Normal-vs-Extreme_Weight |
3.49379999997623E-06 |
| Normal-vs-Obese |
7.815500E-03 |
| Normal-vs-Extreme_Obese |
1.313360E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.845160E-01 |
| Normal_Weight-vs-Obese |
8.877800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.237200E-01 |
| Extreme_Weight-vs-Obese |
1.243840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.324200E-01 |
| Obese-vs-Extreme_Obese |
8.596400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.472200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.222200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.31509999999435E-05 |
| Normal-vs-Age(81-100Yrs) |
1.823370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.776000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.592600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.353600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.123700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.554000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.874600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.5502899999964E-05 |
| Normal-VS-Type2 PRCC |
4.098100E-02 |
| Normal-VS-KIRP CIMP |
8.400200E-01 |
| Normal-VS-Unclassified PRCC |
2.096800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.242500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.558200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.295700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.798400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.804400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.306600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85467999999078E-05 |
| Normal-vs-N1 |
2.163800E-01 |
| Normal-vs-N2 |
7.034000E-01 |
| N0-vs-N1 |
6.877600E-02 |
| N0-vs-N2 |
6.814400E-01 |
| N1-vs-N2 |
9.431400E-01 |
|
|
